Archive for Daily News

MDCO Adcom date set + updates for ACAD ATRA BOTA CMRX GEVA HPTX HSGX ISIS KERX MACK NLNK OTIC PTCT RPTP SAGE SRPT TLOG VICL ZIOP

Feb 28, 2015 No Comments by

Latest updates to the Company Pipeline Database for February 26-27, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ACAD 37.97 Pimavanserin Parkinson’s disease psychosis (PDP) Phase 2 NDA filing due 1Q 2015 2/28/2015 ATRA 19.56 PINTA 745 Protein-energy wasting Phase 2 Phase 2 unblinding of data […]

Daily News Read more

Pipeline updates for ALKS ARDX ATRS BMRN CEMP CLDX CLVS DPRX DYAX EXEL FLXN INFI NKTR TBPH XOMA

Feb 26, 2015 No Comments by

Latest updates to the Company Pipeline Database for February 24-25, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ALKS 71.11 ALKS 5461 Major depressive disorder Phase 2 Phase 3 (two trials) initiated Jun 2014. Data due 2016. Third Phase 3 trial initiated mid 2014. Data due […]

Daily News Read more

BDSI ENDP GEVA ICNY OPHT updates

Feb 24, 2015 No Comments by

Latest updates to the Company Pipeline Database for Monday February 23, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated BDSI 14.63 BEMA Buprenorphine Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate PDUFA Announced Dec 23 […]

Daily News Read more

Updates for week ending February 20

Feb 20, 2015 No Comments

Latest updates to the Company Pipeline Database for week ending February 20, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated AGIO 106.30 AG-348 Pyruvate kinase deficiency Phase 2 Phase 2 trial to be initiated 1H 2015 2/21/2015 ARIA 8.06 Brigatinib – ALTA trial Anaplastic lymphoma kinase […]

Read more

Pipeline updates for ADHD BIOD CYTK GNCA HZNP INCY IRWD MDWD PTN VSAR

Feb 14, 2015 No Comments

Latest updates to the Company Pipeline Database for February 12-13, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ADHD 6.92 MDX (Metadoxine Extended Release (MG01CI)) Fragile X Syndrome Phase 2b Phase 2b enrolment due to be completed 1Q 2015. Data due 2Q 2015 2/14/2015 ADHD 6.92 […]

Read more

Latest updates for TTHI NBIX OHRP GALE KMDA AMAG ANIK AMGN ANTH RGLS LJPC SGEN SGMO

Feb 12, 2015 No Comments

Latest updates to the Company Pipeline Database for February 9-11, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated AMAG 40.05 Makena – single-dose (1 mL) vial Reduce the risk of preterm birth in women with a singleton pregnancy PDUFA FDA decision due 2Q 2015 2/12/2015 AMGN […]

Read more

Updates for SNTA BOTA DERM PTLA

Feb 06, 2015 No Comments

Latest updates to the Company Pipeline Database for February 5, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated BOTA 2.48 Vapendavir Human rhinovirus (HRV) Phase 2b Phase 2b top-line data due mid 2016 2/6/2015 DERM 15.73 DRM04 Primary axillary hyperhidrosis Phase 2b Phase 3 to be […]

Read more

CANF data due by end of March. IMMU lupus data due 1H + pipeline updates for GWPH BIND IRWD MSTX

Feb 05, 2015 No Comments

Latest updates to the Company Pipeline Database for February 4, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated BIND 6.34 BIND-014 Cancer – KRAS mutant Non-small cell lung cancer (NSCLC) Phase 2 Preliminary data due 2H 2015 2/5/2015 BIND 6.34 BIND-014 Cancer – Squamous histology NSCLC […]

Read more

Updates for ASPX ISIS CTIC MRNS + CPXX added to the database.

Feb 04, 2015 No Comments

Latest updates to the Company Pipeline Database for February 3, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ASPX 58.22 SD-809 Tardive Dyskinesia (TD) Phase 2/3 Phase 2b enrolment completed early Feb 2015. Topline data due mid 2015. Data from Phase 3 trial due 2016 2/4/2015 […]

Read more

ARDX disappoints with Phase 2b trial. RPRX files NDA + AQXP CPRX CVM EVOK FLXN HTBX INSV ONTX PLX

Feb 03, 2015 No Comments

Latest updates to the Company Pipeline Database for February 2, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated AQXP 11.27 AQX-1125 FLAGSHIP Chronic obstructive pulmonary disease (COPD) Phase 2 Phase 2 enrolment completed early Feb 2015. Data due mid 2015 2/3/2015 ARDX 19.25 Tenapanor Hyperphosphatemia in […]

Read more

ZGNX FDA Approval + updates for APPY CORT IMGN PCYC RDUS SGYP VCEL VRTX

Jan 31, 2015 No Comments

Expect updates to be streaming in thick and fast over the next two weeks when most small-mid cap companies report 4Q 2014 results. Latest updates to the Company Pipeline Database for January 28-30, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated APPY 0.50 Appy1 Acute appendicitis […]

Read more